Key Takeaways
- FY25 hit plan despite patchy demand: Revenue and profit met targets as strength in refrigeration, dairy, pharma and exports compensated for a weak gas distribution business and slow new-energy execution.
- Order book mix, not size, is the growth signal: The order book rose only 12% but the shift to 60% equipment from packages cut execution cycles from 7 to 5 months, so the backlog supports the 20% sales growth target.
- Tezcatlipoca is the margin-and-scale story: The fully in-house centrifugal compressor is winning repeat orders on lifetime cost and is seen as a Rs. 300–500 crore opportunity in 3–5 years, though it has not yet crossed Rs. 100 crore in annual revenue.
- Margins held at the high end, with a deliberate trade-off: Compression segment profit stayed at 21.7% and management will keep it around 21–22%, but is willing to trade margin for volume to sustain 20% topline growth.
- What to watch next quarter: Whether the Tyche semi-hermetic launch gains commercial traction, the pace of Tezcatlipoca’s scale-up toward Rs. 100 crore, and any recovery in CNG station order inflow.
The 20% Growth Engine: Equipment Mix and Market Share
- Execution cycle shortened: The order book mix moved to 60% equipment and 40% packages, pulling the average execution cycle down from 7 months to 5 months. That means a 12% higher order book can deliver 20% topline growth because more orders booked this year will convert within the same year.
- Market share runway is the structural argument: Management estimates Kirloskar holds only 5–7% of the air compressor market, a very small share in refrigeration, and is probably the only player making most gas packaging and distribution compressors 100% in-house. India remains the largest importer of compressors, so even if the market does not grow for 1–2 years, the Company can keep growing by taking share from imports.
- In-house manufacturing deepens the moat: Facilities for the Tyche semi-hermetic range and lost foam casting for compressor parts were commissioned during the year. Management is consciously bringing forging, fabrication and casting back in-house, learning from the Chinese model of scale and competence, which it says improves speed, customization and cost competitiveness.
- New products follow a proven scaling pattern: Capital goods products need about 10% market share before they scale. Tezcatlipoca took two years for market acceptance then ramped rapidly; Khione had lukewarm bare-shaft sales for two years, then shifted to packaging and picked up well.
K. Srinivasan: "We are a small, small player in a huge developing market, predominantly served with imported inputs. The market itself is India, and I see this 20% growth for a significant period of time is a definite possibility."
Tezcatlipoca: The Fully In-House Centrifugal Compressor
- Unique competitive position: Management claims Kirloskar is the only company making the entire centrifugal compressor in India. Imported alternatives rely on supply chains 7,000 km and above, with parts from China, Europe and the US, making them expensive and slow. Kirloskar’s compressor is designed in-house and manufactured entirely within a 200 km supply chain across three factories.
- Customer proof is in repeat orders: The compressor is delivering what management calls the lowest cost of utilization and lowest lifetime cost, and repeat orders are coming in from metals, carbon black, cement and material-conveying industries. Tezcatlipoca now represents 15–18% of the ACD business, which itself is about 20% of total sales.
- Revenue still sub-scale but poised: Management expects Tezcatlipoca to cross Rs. 100 crore during the current year, though full-year FY25 revenue was significantly below that figure. The medium-term opportunity is pegged at Rs. 300–500 crore in 3–5 years, and the centrifugal compressor market in India is expected to reach about Rs. 500 crore in the next 2–3 years.
K. Srinivasan: "We are the only people who make the entire centrifugal compressor in India, and that gives us a huge advantage."
Gas Business: A Tale of Two Halves
- CNG station mix is deteriorating: Management flagged a continued decline in commissioning of mother stations, with gas companies preferring daughter stations to meet coverage commitments. The booster compressor business that serves daughter stations is marginal, and the Company is reluctant to pick up more orders beyond a point. This is, in management’s words, “not a good sign for us.”
- MENA exports are the offset: Sale of CNG packages to the MENA region is scaling up as countries there find it the quickest way to meet growing energy demand. This, combined with the O&M business operating nearly 1,000 filling stations across 15 states, partly compensates for the weak domestic station-installation trend.
- Long-term gas story intact but lumpy: Management believes the business is not going away; of the 18,000 stations that must come up, about 12,000–14,000 still need to be built. However, order inflow and execution remain in fits and bursts, with periods of good inflow and bad execution, and vice versa.
- Biogas scaling is a science problem, not an intent problem: Compressed biogas is not scaling as fast as expected because generating stable, significant biogas from variable bio-sources remains a technical challenge. Urban waste, spent wash and agri-waste are all being tried, but generation in many projects has been significantly below plan. Kirloskar is an approved Reliance supplier and has the full product range, but growth depends on customers solving the feedstock stability issue.
K. Srinivasan: "We continue to see a decline in commissioning of mother stations and a preference to put up daughter stations. This is clearly to comply with the coverage commitments that the gas companies have made and this is not a good sign for us."
Refrigeration and New Products: The Growth Counterweight
- Refrigeration segment carried the quarter: The refrigeration compression segment grew strongly on the back of cold chains, ice plants, dairy, food processing, pharma, chemicals and fertilizers. This more than compensated for the marginal decline in the gas business, validating management’s claim of being relatively agnostic to market variance across segments.
- Tyche launch targets the import-substitution wedge: Tyche, a semi-hermetic compressor claimed to be the only one made in India, is being launched this year for commercial refrigeration. Management says it is comparable or better than German and Italian imports and significantly better priced. Smaller versions for reefer containers and milk delivery vans are in the pipeline.
- Tyche’s go-to-market is still being learned: The Company will initially sell Tyche as a bare compressor against imports, but if packaged it could partly compete with its own OEM customers. Management is taking a mixed approach, learning from the Khione experience where bare-shaft sales were lukewarm and packaging unlocked the scale-up.
- Product pipeline is deep and deliberately unannounced: Beyond Tyche, Khione packages, Jarilo biogas compressors and the Systems & Components acquisition, management says several other products are not even announced yet and will be revealed only at launch.
K. Srinivasan: "Tyche would be comparable or better than what they get from imports, and obviously significantly better priced than the imported German or the Italian machines."
Margins: High and Willing to Trade
- Compression segment profitability at the top of the range: The compression segment earned a profit of 21.71% in FY25, up from 19.8% in FY24, and has consistently sustained profitability in the 18–20% range. Management expects to keep it around 21–22% directionally.
- Raw material cost improved structurally: The ratio of raw material to sales improved by 1.1 percentage points in FY25, driven by better product mix, better order selection, execution of large packages and export sales. This is a multi-step margin story: exiting decremental activities like transmission and RoadRailer, cost control from in-house manufacturing, better design and engineering, and newer products that are less material-intensive and more engineering-intensive.
- Volume over margin is the stated philosophy: Management is explicit that the capability to deliver superior margins exists, but depending on market conditions it is willing to trade off margins for growth. Most businesses are government or government-related tender-based, and the Company wants to stay competitive on L1 pricing. The focus is on getting scale in volume while keeping EBITDA around 20%.
- Other expenses are semi-variable and rising with scale: Other expenses rose from Rs. 244 crore to Rs. 301 crore, driven by IP updation, maintenance, the Nashik plant addition, power and fuel, and outsourcing costs for the O&M business. These are semi-variable and will move with volume.
K. Srinivasan: "Capability to deliver superior margins exists, but depending on market conditions, we are willing to trade off margins for growth. So all we keep saying is directionally, Company's margin be about 20% EBITDA and the compression segment already 21% plus, we will keep it around 21%, 22%, but we will focus on getting scale in volume."
Capital Allocation and the Inorganic Stance
- Systems & Components acquisition adds a captive outlet: The 55.26% stake in Systems & Components (India) Private Limited, acquired in December 2024, allows scaling up in pharma, chemical and dairy sectors. It also adds one more potential internal customer to the chain, and management expects a significant jump in its top and bottom line during the next year.
- Inorganic growth is opportunistic, not factored into plans: Management will not buy growth and will not factor inorganics too much into projections. It describes itself as a value buyer that passes on tempting opportunities where the price is wrong or the capability does not fit. The Rs. 4,000 crore five-year aspiration can go much bigger if inorganic opportunities fructify, but the base plan does not depend on them.
- Working capital and shareholder returns improved: Net working capital decreased by about Rs. 28 crore over the year to roughly 15% of sales, in line with plan. The Board approved a total dividend of Rs. 10 per share (500%), the highest in any financial year. The Company also reaffirmed its AA- credit rating with a positive outlook.
K. Srinivasan: "We will not buy growth because there is a lot of opportunities which are tempting but it is not the price or it does not bring the capability that the Company is looking for."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue milestone | Cross Rs. 2,000 crore topline | FY26 |
| Topline growth | Deliver 20% plus growth | FY26 |
| Compression segment margin | Maintain around 21–22% | Directional, ongoing |
| Company-level EBITDA margin | About 20% | Directional, ongoing |
| Tezcatlipoca revenue | Cross Rs. 100 crore | Current year (FY26) |
| Medium-term revenue aspiration | Rs. 4,000 crore | In 5 years |
| Sustained growth rate | 20% CAGR for a significant period | Medium term, no end date |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Revenue | ₹583 cr, +19% YoY |
| Total income | ₹588 cr, vs ₹496 cr in Q4 FY24 |
| Raw material to sales | 56.36%, vs 56.21% in Q4 FY24 |
| Staff cost | ₹45.52 cr (7.75% of total income), vs ₹37.88 cr (7.74%) in Q4 FY24 |
| EBITDA margin | 19% of total income (FY25 YTD), vs 16.5% in FY24 |
| PBT margin | 17% of total income (FY25 YTD), vs 13.25% in FY24 |
| Net profit after tax | ₹211 cr (FY25), 12.8% of total income vs ₹133 cr (9.9%) in FY24 |
| EPS | ₹32.50 (FY25), +58% YoY |
| Order book | ₹1,624 cr as of 1 Apr 2025, +12% over opening order book of previous year |
| Order inflow | ₹1,860 cr (FY25), highest ever, +23% YoY |
| Compression segment margin | 21.71% (FY25), vs 19.8% in FY24 |
| Net working capital | ₹272 cr, 15% of sales, down ₹28 cr from beginning of year |
| Free cash from operations | ₹280 cr (FY25) |
| Net cash position | ₹330 cr plus as of 1 Apr 2025 |
| CAPEX | ~₹100 cr (FY25) |
| Export sales | ₹124 cr (FY25), ~10% of sales, +80% YoY |
| Dividend | 500% (₹10 per share), highest in company history |